This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Umab-Biopharma Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Zhichao Wang - Innovator in Biopharmaceuticals
Introduction
Zhichao Wang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for tumors and viral infections. His work is characterized by a strong focus on fusion proteins and their applications in medicine.
Latest Patents
Zhichao Wang holds a patent for a fusion protein and its application in preparing medicine for treating tumors and/or viral infections. The patent describes a fusion protein that comprises an antibody or antigen-binding fragment that specifically binds to human OX40 and a human interferon. This innovative approach aims to enhance the efficacy of pharmaceutical compositions in treating serious health conditions.
Career Highlights
Zhichao Wang is associated with Nanjing Umab-biopharma Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies in oncology and virology.
Collaborations
Zhichao Wang collaborates with notable colleagues, including Shifu Mo and Yong Zhao. These partnerships enhance the research environment and contribute to the development of cutting-edge biopharmaceutical solutions.
Conclusion
Zhichao Wang's innovative work in the field of biopharmaceuticals exemplifies the potential of fusion proteins in medical applications. His contributions are paving the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile